Crinetics Pharmaceuticals, Inc. (CRNX)
47.52
-0.44
(-0.92%)
USD |
NASDAQ |
Dec 29, 16:00
47.54
+0.02
(+0.04%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap: 4.509B for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 13.39B |
| GT Biopharma, Inc. | 9.786M |
| Sutro Biopharma, Inc. | 94.57M |
| NovaBay Pharmaceuticals, Inc. | 612.41M |
| Palatin Technologies, Inc. | 14.46M |
Market Cap Related Metrics
| PS Ratio | 2883.72 |
| PEG Ratio | -0.4772 |
| Price to Book Value | 4.206 |
| Price | 47.52 |
| Earnings Yield | -9.54% |
| PEGY Ratio | -0.4772 |